Keyphrases
COVID-19
100%
Virus
54%
Quantitative PCR
46%
Ebola Virus
43%
Neutralizing Antibodies
31%
United Kingdom
28%
Exocytosis
28%
Care Homes
22%
Weibel-Palade Bodies
22%
SARS-CoV-2 Infection
18%
Ebola
18%
Reinfection
17%
COVID-19 Outbreak
16%
Public Health England
15%
Human Immunodeficiency Virus Type 1 (HIV-1)
15%
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
14%
Q Fever
13%
Monoclonal Antibody
13%
Crimean-Congo Hemorrhagic Fever
13%
Healthcare Workers
13%
Cycle Threshold
13%
Sierra Leone
13%
Ebola Outbreak
12%
Ebola Virus Disease
12%
West Africa
12%
Workplace
11%
Von Willebrand Factor
11%
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
11%
Surface Sampling
11%
SARS-CoV-2 Variants
11%
Convalescent Plasma Therapy
10%
Outbreak Investigation
10%
Polymerase Chain Reaction
10%
Uganda
10%
Bulgaria
10%
Ugandan
10%
Virus RNA
10%
In Care
10%
Virus Challenge
9%
Rab27a
9%
Provirus
9%
Ebola Virus Infection
9%
Synaptotagmin
9%
Antibody Response
9%
Europe
9%
Non-fatal
9%
Biosafety Level 4
9%
Vietnam
9%
Transmissibility
9%
Multicenter Cohort Study
9%
Virion
9%
Plasma Membrane
9%
Ferret
9%
Detergent
9%
June 2014
9%
Fatal Case
9%
Siren
9%
Sanitation
9%
Ministry of Health
9%
Biobank
9%
Bacillus Anthracis
9%
Makona
9%
Anthracis
9%
SARS-CoV-2 Outbreak
9%
Omicron Variant
9%
Live Attenuated Influenza Vaccine
9%
Poliovirus
9%
Convalescent Plasma
8%
Infectious Virus
8%
PCR Test
8%
Viral Hemorrhagic Fever
8%
Filovirus
8%
Laboratory Confirmation
8%
Crimean-Congo Hemorrhagic Fever Virus (CCHFV)
8%
Endothelial Cells
8%
Coronavirus
7%
Guinea pig Model
7%
Amino Acid Sequence
7%
Sequence Analysis
7%
Causative Agents
7%
Convalescent
7%
PCR Cycles
7%
Nucleic Acid Extraction
7%
Highly Pathogenic
7%
Virus Isolation
6%
Bacteriophage
6%
Confidence Interval
6%
Monkeypox
6%
Recombinant
6%
Targeting Antibodies
6%
Polymerase Chain Reaction Assay
6%
Enzyme-linked Immunosorbent Assay (ELISA)
6%
Natural Infection
6%
Patient Samples
6%
Herpes Simplex Virus 2 (HSV-2)
6%
Virus-neutralizing Antibody
6%
Mouse Model
6%
Guinea pig
6%
Antibody Test
6%
Confirmed Cases
6%
Immunology and Microbiology
Ebola Virus
58%
Immunology
51%
Severe Acute Respiratory Syndrome Coronavirus 2
47%
Exocytosis
32%
Blood Plasma
25%
Weibel Palade Body
22%
Neutralizing Antibody
22%
Spike
16%
Influenza
13%
COVID-19
12%
Viral Disease
12%
Coronavirinae
11%
Lineages
11%
Human Immunodeficiency Virus 1
10%
Provirus
10%
Middle East Respiratory Syndrome Coronavirus
10%
Secretion (Process)
9%
Dynamics
9%
Cell Membrane
9%
Hemorrhagic Fever
9%
Epitope
9%
Poliomyelitis Virus
9%
Viral Shedding
9%
Omicron Coronavirus Variant
9%
Virion
9%
Influenza Vaccine
9%
Immunoassay
9%
Mustela Putorius Furo
9%
Human Monoclonal Antibody
9%
Immunodeficiency
9%
Filovirus
9%
Bacillus Anthracis
9%
Antibody Response
8%
Wild Type
8%
Reverse Transcription Polymerase Chain Reaction
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
SARS Coronavirus
7%
Amino Acid Sequence
7%
Cladistics
7%
Guinea Pig
7%
P-Selectin
7%
Monoclonal Antibody
6%
Neutralization
6%
Serotype
6%
Guinea Pig Model
6%
Bacteriophage
6%
Receptor Binding
6%
Glycoprotein
6%
Cell Surface
6%
Enzyme-Linked Immunosorbent Assay
5%
Mouse Model
5%
Viral Load
5%
Reverse Transcription Polymerase Chain Reaction
5%
Memory B Cell
5%
Therapeutic Antibodies
5%
Transcriptomics
5%
Normal Human
5%
Virus Antibody
5%
Cell Line
5%
Crimean-Congo Hemorrhagic Fever Virus
5%
Viral Replication
5%
Liquid
5%
Sequence Analysis
5%
Gene Expression Assay
5%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
82%
Infection
49%
Ebolavirus
34%
COVID-19
31%
Public Health
21%
Neutralizing Antibody
19%
Endothelial Cell
16%
Health Care
16%
Exocytosis
15%
Diagnosis
14%
Crimean-Congo Hemorrhagic Fever
13%
Weibel-Palade Body
13%
Reinfection
13%
Quantitative Reverse Transcription Polymerase Chain Reaction
13%
Disease
11%
Virus Infection
10%
In Vitro
9%
Synaptotagmin
9%
Fatality
9%
Guanidine
9%
Reverse Transcription Polymerase Chain Reaction
9%
Nucleic Acid
8%
Von Willebrand Factor
8%
Human Immunodeficiency Virus
8%
SARS Coronavirus
7%
Severe Acute Respiratory Syndrome
7%
Virus Genome
7%
Virus RNA
6%
Infection Control
6%
Prevalence
6%
Immunoassay
6%
Polymerase Chain Reaction
6%
Cohort Analysis
6%
Virus Isolation
5%
Receptor Binding
5%
Rapid Test
5%
Coronaviridae
5%
Viral Hemorrhagic Fever
5%
Secretion (Process)
5%
Coronavirinae
5%
Clinical Feature
5%
Infection Rate
5%